Results 171 to 180 of about 8,509 (214)

Enhanced methods for genetic assays in Drosophila cells

open access: yes
Wang Y   +4 more
europepmc   +1 more source

Vascular Disruption Therapy as a New Strategy for Cancer Treatment. [PDF]

open access: yesInt J Mol Sci
Gómez-Escudero J   +8 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Calibration characteristics of a video dimension analyser (VDA) system

Journal of Biomechanics, 1992
A comprehensive calibration and error analysis of a video dimension analyser (VDA) system was carried out to determine the effects of various parameters relevant to actual test conditions on the characteristics of the system. The parameters considered were: (1) varying distances or angles between the test specimen and the camera; (2) refractive effects
Cyril B Frank, N G Shrive, N G Shrive
exaly   +3 more sources

Prüfprozesseignung nach VDA 5

2015
Achim Kistner, Bertram Schäfer
exaly   +2 more sources

Anticancer Agents: VTA or VDA

Current Bioactive Compounds, 2009
The tumor vasculature is quite an attractive target for anti-cancer/anti-tumor therapy because the blood vessels provide the route for nutrient/waste and oxygen/carbon dioxide exchanges as well as a convenient route for tumor metastatic spread. The complex interplay of the tumor with the local blood vasculature is intriguing.
Paul Sebahar   +2 more
openaire   +1 more source

Vascular Disrupting Agents (VDAs) in Anticancer Therapy

Current Clinical Pharmacology, 2010
Vascular disrupting agents (VDAs) represent a novel class of drugs targeting the tumor's blood supply. Conceptually and operationally different from currently used antiangiogenic agents, VDAs have a high specificity for the established but abnormal tumor vasculature.
Laura G M, Daenen   +3 more
openaire   +2 more sources

Die Überarbeitung von VDA 19 beginnt: Erfahrungen und Feedback nach sieben Jahren VDA 19

open access: yes, 2012
Hohe Anforderungen an die Sauberkeit von Bauteilen und Systemen, die die komplette Zulieferkette betreffen können, sind aus der Automobilindustrie nicht mehr wegzudenken.
Rochowicz, Markus
core   +3 more sources

Combination Therapy with Chemotherapy and VDAs

2010
A growing body of preclinical and clinical evidence substantiates the feasibility of combining vascular disrupting agents (VDAs) and conventional anticancer therapies. The enhanced disease response to this combination is attributable to the respective activity of VDAs on the tumor vasculature and of the cytotoxic drug on proliferating tumor cells ...
Giulia Taraboletti   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy